Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lavanchy

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|September 10, 1994
Seroprevalence of hepatitis E virus in SwitzerlandD Lavanchy, B Morel, P C Frei
Journal of Clinical Laboratory Analysis|January 1, 1990
Modified dot assay with increased sensitivity: detection of small amounts of immunoglobulin molecules and the importance of different detection systemsD Lavanchy, J Stroun, P C Frei
Reviews in Medical Virology|March 10, 2001
Planning for the next pandemic of influenzaI D Gust, A W Hampson, D Lavanchy
Infection|January 1, 1986
Immune response to purified non-A, non-B hepatitis-related antigen demonstrated by leukocyte migration inhibition in patients recovering from the infectionA Nicole, O Spertini, D Lavanchy, et al.
Journal of Clinical Laboratory Analysis|January 1, 1996
Evaluation of a new automated third-generation anti-HCV enzyme immunoassayD Lavanchy, J Steinmann, A Möritz, et al.
Journal of Hepatology|September 1, 1992
Monitoring of interferon-alpha treatment in chronic active hepatitis BD Lavanchy, C Mayerat, P C Frei, et al.
Schweizerische Medizinische Wochenschrift|December 10, 1988
[Prognostic significance of the T4 lymphocyte count in patients infected with CDC Class II and III HIV]S Rüttimann, J D Lavanchy, J L Meyer, et al.
International Journal of Clinical Practice|February 28, 2001
Neuraminidase inhibitors: progress in the management of influenzaM Woodhead, D Lavanchy, S Johnston, et al.
Revue Medicale De La Suisse Romande|May 1, 1992
[Seroprevalence of cytomegalovirus infections in patients on hemodialysis, renal allograft recipients and the general population of French-speaking Switzerland]P Lopez-Mata, D Lavanchy, J P Wauters, et al.
Journal of Clinical Microbiology|November 1, 1996
Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitationC Mayerat, P Bürgisser, D Lavanchy, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|September 10, 1994
Seroprevalence of hepatitis E virus in SwitzerlandD Lavanchy, B Morel, P C Frei
Journal of Clinical Laboratory Analysis|January 1, 1990
Modified dot assay with increased sensitivity: detection of small amounts of immunoglobulin molecules and the importance of different detection systemsD Lavanchy, J Stroun, P C Frei
Reviews in Medical Virology|March 10, 2001
Planning for the next pandemic of influenzaI D Gust, A W Hampson, D Lavanchy
Infection|January 1, 1986
Immune response to purified non-A, non-B hepatitis-related antigen demonstrated by leukocyte migration inhibition in patients recovering from the infectionA Nicole, O Spertini, D Lavanchy, et al.
Journal of Clinical Laboratory Analysis|January 1, 1996
Evaluation of a new automated third-generation anti-HCV enzyme immunoassayD Lavanchy, J Steinmann, A Möritz, et al.
Journal of Hepatology|September 1, 1992
Monitoring of interferon-alpha treatment in chronic active hepatitis BD Lavanchy, C Mayerat, P C Frei, et al.
Schweizerische Medizinische Wochenschrift|December 10, 1988
[Prognostic significance of the T4 lymphocyte count in patients infected with CDC Class II and III HIV]S Rüttimann, J D Lavanchy, J L Meyer, et al.
International Journal of Clinical Practice|February 28, 2001
Neuraminidase inhibitors: progress in the management of influenzaM Woodhead, D Lavanchy, S Johnston, et al.
Revue Medicale De La Suisse Romande|May 1, 1992
[Seroprevalence of cytomegalovirus infections in patients on hemodialysis, renal allograft recipients and the general population of French-speaking Switzerland]P Lopez-Mata, D Lavanchy, J P Wauters, et al.
Journal of Clinical Microbiology|November 1, 1996
Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitationC Mayerat, P Bürgisser, D Lavanchy, et al.
Pageof 6